Clinical Trials in Cleveland

Showing 7161-7180 of 15,050 trials

Safety Study of the VEGA UV-A System to Treat Ectasia

NCT01398839

The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.

Ectasia

Topcon Medical Systems, Inc.103 participantsStarted Dec 2010

Phoenix, Arizona, United States • Atlanta, Georgia, United States • Bloomington, Minnesota, United States +9 more locations

TERMINATEDNA< 1 mile

SHIELD II Clinical Investigation

NCT02468778

The HeartMate PHP System is a temporary (\<6 hours) ventricular assist device indicated for use during high-risk percutaneous coronary interventions (PCI) performed electively or urgently in hemodynamically stable patients with severe coronary artery disease, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the HeartMate PHP Systems in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri-and post-procedural adverse events.

Coronary Artery Disease

Abbott Medical Devices54 participantsStarted Aug 2015

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +55 more locations

Safety Study of the VEGA UV-A System to Treat Ectasia

SHIELD II Clinical Investigation

Find Trials by Condition in Cleveland

Improving Sexual Health in Gynecologic Cancer Patients

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Rhythmic Auditory Stimulation and Walking Performance in Multiple Sclerosis (MS) Patients

MOMENTUM 3 IDE Clinical Study Protocol

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody

Glycemic Response in Adults With Type 2 Diabetes

Esteem New Subject Enrollment Post Approval Study

Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD